Spots Global Cancer Trial Database for imrt
Every month we try and update this database with for imrt cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study Comparing RT With Cetuximab + Xevinapant to RT With Cetuximab-placebo in Patients With Head and Neck Cancer | NCT05930938 | Squamous Cell C... | Xevinapant Placebo cetuximab IMRT | 18 Years - 79 Years | Groupe Oncologie Radiotherapie Tete et Cou | |
| FDG-PET Directed Treatment in Improving Response in Patients With Locally Advanced Stomach or Gastroesophageal Junction Cancer | NCT02485834 | Adenocarcinoma ... Gastric Adenoca... Gastric Cancer | FDG-PET surgery 5-FU capecitabine docetaxel Irinotecan 3D-CRT IMRT | 18 Years - | Alliance for Clinical Trials in Oncology | |
| A Clinical Trial to Reduce Skin Burn Induced by Breast Radiotherapy Using Intensity Modulated Radiation Therapy (IMRT) | NCT00187343 | Breast Neoplasm... | Breast IMRT | - | Sunnybrook Health Sciences Centre | |
| Mild Hypofractionation With Proton Therapy or Intensity Modulated Radiation Therapy (IMRT) for Intermediate-Risk Prostate Cancer | NCT01352429 | Prostate Adenoc... | Proton Therapy IMRT | 18 Years - | Abramson Cancer Center at Penn Medicine | |
| Study of I-125 Brachytherapy Versus Intensity-modulated Radiation Therapy to Treat Inoperable Salivary Gland Cancer | NCT02048254 | Salivary Gland ... | brachytherapy IMRT | 18 Years - 80 Years | Peking University | |
| Radiation Dosimetry Study Comparing 2 Different Patient Setups in Anal/Rectal Cancer Patients | NCT00693173 | Anal Cancer | 18 Years - 80 Years | The University of Texas Medical Branch, Galveston | ||
| Stem Cell Radiotherapy and Temozolomide for Newly Diagnosed High-grade Glioma | NCT02039778 | Glioblastoma Malignant Gliom... Brain Tumors Anaplastic Astr... | Stem Cell Radio... | 18 Years - 70 Years | Beth Israel Medical Center | |
| Dose Escalation Radiotherapy With Modulation of Intensity and Integrated Boost (SIB-IMRT) in the Treatment of Glioblastomas in Adults | NCT01043536 | Glioblastoma | radiotherapy temozolomide | 18 Years - 70 Years | Centre Georges Francois Leclerc | |
| Accelerated Partial Breast Radiotherapy With Either Mammosite or Intensity Modulated Radiotherapy | NCT01185145 | Breast Cancer | Breast Brachyth... Intensity Modul... | 40 Years - | Rocky Mountain Cancer Centers | |
| Randomized Trial of Avelumab-cetuximab-radiotherapy Versus SOCs in LA SCCHN (REACH) | NCT02999087 | HNSCC | Cetuximab avelumab Cisplatin IMRT | 18 Years - 80 Years | Groupe Oncologie Radiotherapie Tete et Cou | |
| Proton Beam Therapy (PBT) Versus Intensity-Modulated Radiation Therapy (IMRT) Trial | NCT01512589 | Esophageal Canc... | Proton Beam The... Intensity Modul... Questionnaires | 18 Years - | M.D. Anderson Cancer Center | |
| Stereotactic Body Radiotherapy (SBRT) for Prostate Cancer | NCT00941915 | Prostate Cancer | SBRT Prostate | 40 Years - 82 Years | Duke University | |
| CIETAI and Sequential Radiotherapy in Squamous Lung Cancer | NCT05892237 | Carcinoma, Non-... | bronchial arter... Chemotherapy dr... IMRT Immunotherapy | 18 Years - 80 Years | Third Military Medical University | |
| Programmed Death-1 (PD-1) Antibody Combined With Chemoradiotherapy in High-risk Recurrent Nasopharyngeal Carcinoma | NCT03930498 | Recurrent Nasop... | PD-1 blocking a... Chemotherapy IMRT | 18 Years - 65 Years | Sun Yat-sen University | |
| A Multicenter Randomized Controlled Clinical Study on the Treatment of T3N1M0 High Risk Nasopharyngeal Carcinoma With or Without Induction Chemotherapy Before Concurrent Radiotherapy and Chemotherapy | NCT05622474 | Nasopharyngeal ... | Induction chemo... Concurrent chem... IMRT | 18 Years - 70 Years | Sun Yat-sen University | |
| IMRT Plus Cisplatin Versus Conventional Radiotherapy Plus Cisplatin in Stage III-IV HNSCC | NCT00158678 | Oral Cancer Oropharynx Canc... Hypopharynx Can... | IMRT 75 Gy Conventional ra... concomitant cis... | 18 Years - | Groupe Oncologie Radiotherapie Tete et Cou | |
| The Effect of Bone Marrow-sparing Intensity-Modulated Radiotherapy to GI Cancer | NCT01863420 | Rectal Cancer Gastric Cancer Bone Marrow Tox... Adverse Effect ... | Bone Marrow-spa... | 18 Years - 75 Years | ChineseAMS | |
| ROMAN: Phase 3 Trial Investigating the Effects of GC4419 on Radiation Induced Oral Mucositis in Head/Neck Cancer Patients | NCT03689712 | Oral Mucositis | GC4419 90mg Placebo | 18 Years - | Galera Therapeutics, Inc. | |
| Dose-escalation Trial of Preoperative Radiotherapy and Concurrent Chemotherapy in Locally Advanced Rectal Cancer | NCT02964468 | Locally Advance... | 3DCRT treatment... Dose Escalation... | 18 Years - 90 Years | Grupo de Investigación Clínica en Oncología Radioterapia | |
| IMRT-SIB and Capecitabine in Preoperative Rectal Cancer Treatment | NCT02268006 | Rectal Carcinom... | IMRT-SIB Capecitabine Surgery | 18 Years - 90 Years | Institute of Oncology Ljubljana | |
| Spleen Radiotherapy Decreases Severe CIT in Advanced NSCLC (SPLEENIR) | NCT02650700 | Chemotherapy in... | spleen radiothe... | 18 Years - 75 Years | Xinqiao Hospital of Chongqing | |
| Dose-escalation Trial of Preoperative Radiotherapy and Concurrent Chemotherapy in Locally Advanced Rectal Cancer | NCT02964468 | Locally Advance... | 3DCRT treatment... Dose Escalation... | 18 Years - 90 Years | Grupo de Investigación Clínica en Oncología Radioterapia | |
| IMRT and Primary Transoral Surgery in the Treatment of Squamous Cell Carcinomas | NCT04224389 | Squamous Cell C... | transoral resec... IMRT | 18 Years - | Gustave Roussy, Cancer Campus, Grand Paris | |
| S-1 Combined With IMRT Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma | NCT03668366 | Nasopharyngeal ... | S-1 | 18 Years - 80 Years | Fudan University | |
| Dosimetric Planning Study Comparing Intensity Modulated Radiotherapy (IMRT) and 4-field Radiotherapy for Definitive Treatment of Cancer of the Cervix | NCT00981552 | Cervix Cancer | IMRT planning 4-Field Radiati... | - | Sunnybrook Health Sciences Centre | |
| Dose-escalation Trial of Preoperative Radiotherapy and Concurrent Chemotherapy in Locally Advanced Rectal Cancer | NCT02964468 | Locally Advance... | 3DCRT treatment... Dose Escalation... | 18 Years - 90 Years | Grupo de Investigación Clínica en Oncología Radioterapia | |
| IMRT Tomotherapy for Esophagus Cancer | NCT00593723 | Esophagus Cance... | IMRT | 18 Years - | Washington University School of Medicine | |
| Trimodality Management of T1b Esophageal Cancers | NCT01217060 | Esophageal Canc... | Docetaxel 5-FU Radiotherapy Esophagectomy Dexamethasone | 18 Years - | M.D. Anderson Cancer Center | |
| Phase II Study of Intensity Modulated Radiotherapy in Dose Painting for Sinus Carcinomas After Endoscopic Surgery | NCT05943119 | Tumor, Solid | Radiotherapy in... Standard pan-si... | 18 Years - | Centre Francois Baclesse | |
| Study of 3-Dimensional Conformal Radiotherapy (3D-CRT) Versus Intensity Modulated Radiotherapy (IMRT) for Head and Neck Squamous Cell Carcinoma (HNSCC) | NCT00652613 | Squamous Cell C... | 3 Dimensional R... Intensity Modul... | 18 Years - 65 Years | Tata Memorial Hospital | |
| Optimized Intensity Modulated Irradiation for Head and Neck Cancer | NCT00580983 | Head and Neck C... | IMRT Paclitaxel Carboplatin Cisplatin 5-Fluorouracil | 18 Years - | University of Michigan Rogel Cancer Center | |
| RapidPlan Models Establishment for Node-Positive Breast Cancer Treated With Hypofractionation Using Edge/Truebeam | NCT05486936 | Breast Cancer | hypofractionate... | 18 Years - 75 Years | Ruijin Hospital | |
| Nimotuzumab for Recurrent Nasopharyngeal Carcinoma | NCT03666221 | Recurrent Nasop... | Nimotuzumab | 18 Years - 70 Years | Fujian Cancer Hospital | |
| Induction Chemotherapy of TPX in Nomogram-predicted High Risk Locoregionally Advanced Nasopharyngeal Carcinoma | NCT02786641 | Nasopharyngeal ... | Docetaxel Cisplatin 1 Xeloda IMRT Cisplatin 2 | 18 Years - 65 Years | Sun Yat-sen University | |
| Pembrolizumab in Combination With Cisplatin and Intensity Modulated Radiotherapy (IMRT) in Head and Neck Cancer | NCT02777385 | Head and Neck S... | Pembrolizumab Cisplatin IMRT | 18 Years - | University of Pittsburgh | |
| Phase I Study of Olaparib Combined With Cisplatin-based Chemoradiotherapy to Treat Locally Advanced Head and Neck Cancer | NCT02308072 | Head and Neck C... | Olaparib Cisplatin IMRT | 18 Years - | University College, London | |
| Functional Imaging in HNC Undergoing Chemoradiation | NCT00837980 | Head and Neck C... | 18 Years - | Royal Marsden NHS Foundation Trust | ||
| Intensity-Modulated Radiation Therapy & Nivolumab for Recurrent or Second Primary Head & Neck Squamous Cell Cancer | NCT03521570 | Recurrent Head ... | IMRT Nivolumab | 18 Years - | Emory University | |
| CRT Versus Surgery for Retroperitoneal or Paraaortic Lymph Node Recurrence of CRC | NCT03725254 | Colorectal Canc... Retroperitoneal... Para-aortic Lym... | lymphadenectomy chemoradiothera... | 18 Years - 75 Years | Fudan University | |
| Phase III Study Comparing 3D Conformal Radiotherapy and Conformal Radiotherapy IMRT to Treat Endometrial Cancer | NCT01641497 | Endometrial Can... | 3D conformation... IMRT | 70 Years - | Centre Oscar Lambret | |
| Accelerated Partial Irradiation of the Breast: New Altered Fractionation | NCT04101656 | Breast Cancer | 40 Years - | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | ||
| Neoadjuvant Treatment Associated With Maintenance Therapy by Anti-PD1 Immunotherapy in Patients With Resectable Head and Neck Mucosal Melanoma | NCT03313206 | Head and Neck M... | Pembrolizumab Surgery IMRT Lenvatinib | 18 Years - | Gustave Roussy, Cancer Campus, Grand Paris | |
| Post-operative Radiation With IMRT in the Management of Stage IIB-III Breast Cancer | NCT00508352 | Breast Cancer | Helical tomothe... | 18 Years - | Ottawa Hospital Research Institute | |
| Trial of Magnetic Resonance Imaging Guided Radiotherapy Dose Adaptation in Human Papilloma Virus Positive Oropharyngeal Cancer | NCT03224000 | Malignant Neopl... Oropharyngeal C... | Modified Barium... Swallowing Ques... Symptom Questio... Video-Strobe Pr... MRI Guided Inte... Standard-of-Car... Intensity Modul... | 18 Years - | M.D. Anderson Cancer Center | |
| Intensity Modulated Radiotherapy (IMRT) for the Pelvis Post-Hysterectomy | NCT00508703 | Uterine Cancer Cervical Cancer Endometrial Can... | Intensity Modul... CT Scan | - | M.D. Anderson Cancer Center | |
| Safety and Efficacy Study of Nimotuzumab Plus Neoadjuvant and Concurrent Chemoradiotherapy to Treat Oropharynx and Hypopharynx Cancer | NCT01516996 | Oropharyngeal C... Hypopharyngeal ... | docetaxel and c... IMRT Nimotuzumab | 18 Years - 70 Years | The Second People's Hospital of Sichuan | |
| Reduced-dose Versus Standard Dose Radiotherapy for Nasopharyngeal Carcinomain | NCT05304468 | Nasopharyngeal ... | IMRT induction chemo... cisplatin concu... | 18 Years - 70 Years | Sun Yat-sen University | |
| Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN, High Risk, Cisplatin-ineligible Participants (XRAY VISION) | NCT05386550 | Head and Neck C... | Xevinapant (Deb... IMRT Placebo | 18 Years - | EMD Serono | |
| Stereotactic Body Radiotherapy vs Intensity-modulated Radiotherapy in Prostate Cancer | NCT02339701 | Prostate Cancer | IMRT SBRT | 18 Years - | Chinese University of Hong Kong | |
| Glioblastoma Multiforme (GBM) Proton vs. Intensity Modulated Radiotherapy (IMRT) | NCT01854554 | Brain Cancer | IMPT IMRT Cognitive Tests Questionnaires | 18 Years - | M.D. Anderson Cancer Center | |
| Parotid-gland Stem-cell Sparing Intensity-modulated Radiotherapy | NCT01955239 | Head and Neck C... | Intensity-modul... | 18 Years - | University Medical Center Groningen | |
| Image-guided and Intensity-modulated Radiotherapy Versus External Beam Radiotherapy for Patients With Spine Metastases | NCT02832830 | Vertebral Bony ... | IMRT fractionated RT | 18 Years - 85 Years | Heidelberg University | |
| A Clinical Trial to Reduce Skin Burn Induced by Breast Radiotherapy Using Intensity Modulated Radiation Therapy (IMRT) | NCT00187343 | Breast Neoplasm... | Breast IMRT | - | Sunnybrook Health Sciences Centre | |
| Intensity Modulated Radiotherapy With Concomitant Boost in Breast Cancer | NCT03471741 | Breast Cancer Radiation Toxic... | IMRT with conco... 3D-RT with sequ... | - | IRCCS Azienda Ospedaliero-Universitaria di Bologna | |
| Pre-operative 3-DCRT vs IMRT for Locally Advanced Rectal Cancer | NCT02151019 | Locally Advance... | IMRT | 18 Years - | Cancer Trials Ireland | |
| Phase II Study of IMRT With SIB as Adjuvant Treatment for High Risk Resected Well-differentiated Thyroid Cancer. | NCT00279721 | Thyroid Neoplas... | IMRT | 18 Years - | AHS Cancer Control Alberta | |
| Adjuvant Regional Nodal Radiation Therapy for One Week in Breast Cancer | NCT04509648 | Breast Cancer | External Beam r... | 18 Years - | Ruijin Hospital | |
| Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinoma | NCT03174275 | Carcinoma, Squa... Oral Cancer Oropharynx Canc... Larynx Cancer Lip Cancer Esophageal Canc... | Durvalumab Carboplatin Nab-paclitaxel Cisplatin Surgical resect... IMRT | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Adaptive Radiotherapy for Head and Neck Cancer | NCT03096808 | Head and Neck C... Paranasal Sinus... Oropharynx Canc... Oral Cavity Can... Nasopharynx Can... Larynx Cancer Hypopharynx Can... | Adaptive Radiot... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| PEG-ASP+Gemoxd vs. PEG-ASP+CHOP as First-line Chemotherapy to Treatment NK/T-cell Lymphoma With Early Stage | NCT02918747 | Lymphoma | pegaspargase Gemcitabine Oxaliplatin Dexamethasone Cyclophosphamid... Doxorubicin Vincristine Prednisone IMRT | 18 Years - 70 Years | Hunan Cancer Hospital | |
| TOMO Versus IMRT in Nasopharyngeal Carcinoma Patients | NCT03588403 | Nasopharyngeal ... | TOMO IMRT | 18 Years - 65 Years | Zhejiang Cancer Hospital | |
| Safety and Efficacy Study of Nimotuzumab Plus Neoadjuvant and Concurrent Chemoradiotherapy to Treat Oropharynx and Hypopharynx Cancer | NCT01516996 | Oropharyngeal C... Hypopharyngeal ... | docetaxel and c... IMRT Nimotuzumab | 18 Years - 70 Years | The Second People's Hospital of Sichuan | |
| The Effect of Bone Marrow-sparing Intensity-Modulated Radiotherapy to GI Cancer | NCT01863420 | Rectal Cancer Gastric Cancer Bone Marrow Tox... Adverse Effect ... | Bone Marrow-spa... | 18 Years - 75 Years | ChineseAMS | |
| IMRT and Primary Transoral Surgery in the Treatment of Squamous Cell Carcinomas | NCT04224389 | Squamous Cell C... | transoral resec... IMRT | 18 Years - | Gustave Roussy, Cancer Campus, Grand Paris | |
| SBRT and LDRT Combined With PD-1 Antibody and Chemotherapy in r/m Nasopharyngeal Carcinoma | NCT06323239 | Nasopharyngeal ... | SBRT Low-dose Radiot... Toripalimab Gemcitabine Cisplatin IMRT | 18 Years - 75 Years | Sun Yat-sen University | |
| PD-1 Antibody Combined With Chemoradiotherapy in Recurrent Nasopharyngeal Carcinoma Patients | NCT03907826 | Recurrent Nasop... | PD-1 blocking a... GP IMRT | 18 Years - 70 Years | Sun Yat-sen University | |
| A Study of Intensity-modulated Radiotherapy in Patients With Squamous Cell Carcinoma of Unknown Primary (SCCUP) of the Head and Neck | NCT02112344 | Head and Neck C... | IMRT | 18 Years - | Royal Marsden NHS Foundation Trust | |
| Super Hypofractionated Irradiation For Whole Breast Treatment | NCT04926766 | Breast Cancer | External Beam r... | 18 Years - | Ruijin Hospital | |
| Intensity-Modulated Radiation Therapy & Nivolumab for Recurrent or Second Primary Head & Neck Squamous Cell Cancer | NCT03521570 | Recurrent Head ... | IMRT Nivolumab | 18 Years - | Emory University | |
| Phase II Trial of Conventional Versus IMRT Whole Brain Radiotherapy for Brain Metastases | NCT01890278 | Metastatic Brai... | Whole Brain IMR... Conventional Wh... | 18 Years - | Good Samaritan Hospital Medical Center, New York | |
| TRYHARD: Radiation Therapy Plus Cisplatin With or Without Lapatinib in Treating Patients With Head and Neck Cancer. | NCT01711658 | Non-HPV Locally... | IMRT Cisplatin placebo Lapatinib | 18 Years - | Radiation Therapy Oncology Group | |
| A Trial Comparing Intensity Modulated Radiation Therapy (IMRT) With Conventional Radiation Therapy in Stage IIB Carcinoma Cervix | NCT00193804 | Cancer of Cervi... | IMRT | 18 Years - 65 Years | Tata Memorial Hospital | |
| Intensity Modulated Radiotherapy (IMRT) for the Pelvis Post-Hysterectomy | NCT00508703 | Uterine Cancer Cervical Cancer Endometrial Can... | Intensity Modul... CT Scan | - | M.D. Anderson Cancer Center | |
| PEG-ASP+Gemoxd vs. PEG-ASP+CHOP as First-line Chemotherapy to Treatment NK/T-cell Lymphoma With Early Stage | NCT02918747 | Lymphoma | pegaspargase Gemcitabine Oxaliplatin Dexamethasone Cyclophosphamid... Doxorubicin Vincristine Prednisone IMRT | 18 Years - 70 Years | Hunan Cancer Hospital | |
| The Role of Induction Chemotherapy for High-risk Locally Advanced Nasopharyngeal Carcinoma in the Era of IMRT | NCT01797900 | Nasopharyngeal ... | Cisplatin Paclitaxel IMRT | 18 Years - 70 Years | ChineseAMS | |
| Clinical Trial Comparing 3-D RT vs. IMRT in Post- Prostatectomy Prostate Cancer Patients | NCT02678520 | Prostate Cancer | 3-D Conformal R... Intensity Modul... Casodex, Zolade... | 18 Years - | University of Kansas Medical Center | |
| Phase I Study of Olaparib Combined With Cisplatin-based Chemoradiotherapy to Treat Locally Advanced Head and Neck Cancer | NCT02308072 | Head and Neck C... | Olaparib Cisplatin IMRT | 18 Years - | University College, London | |
| Study of IMRT Radiotherapy Concurrent Chemothrerapy for Anal Cancer | NCT03381352 | Anal Cancer | Chemo-radiother... Capecitabine Mitomycin C | 18 Years - 70 Years | ChineseAMS | |
| Using Intensity Modulated Radiation Therapy (IMRT) for Brain Metastases | NCT00328575 | Neoplasm Metast... | Intensity-Modul... | 18 Years - | Thomas Jefferson University | |
| SBRT and LDRT Combined With PD-1 Antibody and Chemotherapy in r/m Nasopharyngeal Carcinoma | NCT06323239 | Nasopharyngeal ... | SBRT Low-dose Radiot... Toripalimab Gemcitabine Cisplatin IMRT | 18 Years - 75 Years | Sun Yat-sen University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
